Evidence map›Paper›PMID 32825242›Full record

ReviewInternational journal of molecular sciences2020

Chemical and Genetic Zebrafish Models to Define Mechanisms of and Treatments for Dopaminergic Neurodegeneration.

Ola Wasel, Jennifer L Freeman

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Zebrafish: A Versatile and Powerful Model for Biomedical Research.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ola WaselSchool of Health Sciences, Purdue University, West Lafayette, IN 47907, USA.
Jennifer L FreemanSchool of Health Sciences, Purdue University, West Lafayette, IN 47907, USA.ORCID 0000-0002-3669-9111
Purdue University West Lafayette · US

Funding

University of Cincinnati Education and Research CenterT42OH008432 · OH · UNIVERSITY OF CINCINNATI · PI DAVIS, KERMIT G. · 2005 to 2025
$32.7M
Occupational Safety and Health, ERC, University of Illinois at ChicagoT42OH008672 · OH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BUCHANAN, SUSAN NATHALIE · 2005 to 2025
$32.7M
NIOSH CDC HHS T42OH008432NIOSH CDC HHS T42 OH008672NIOSH CDC HHS T42OH008672
6 · The paper itself

Abstract

The zebrafish (

Indexed as

AnimalsDisease Models, AnimalDopamineDopaminergic NeuronsGene Knockdown TechniquesNeurotoxicity SyndromesOxidopamineParaquatParkinson DiseaseParkinsonian DisordersProtein Serine-Threonine KinasesPTEN-Induced Putative KinaseRotenoneZebrafishZebrafish ProteinsDopamineOxidopamineParaquatPink1 protein, zebrafishProtein Serine-Threonine KinasesPTEN-Induced Putative KinaseRotenoneZebrafish Proteinsdj1dopamineMPTPneurotransmissionparaquatParkinson’s diseasepink1prknrotenonezebrafish

Identifiers

PMID32825242
PMCPMC7503535
OpenAlexW3055728959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.